drugset / Trial / NCT00479492

Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

NCT00479492 ↗

Phase 2 Completed 94 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether CP-866,087 is effective in the weight loss of overweight patients.

Timeline

Start
2007-06
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject CP-866,087 Small molecule 1 mg —
Subject CP-866,087 Small molecule 5 mg —
Subject CP-866,087 Small molecule 10 mg —

Indications